Research Group
Gastrointestinal and Other Cancers
Sponsor
Massachusetts General Hospital
Status
Active, not recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT02394769
This research study is investigating the use of aspirin as a potential chemopreventive agent
to reduce risk of colorectal cancer
to reduce risk of colorectal cancer
Intervention
Placebo for Aspirin, Aspirin
Condition
Colorectal Cancer
Investigators
Andrew T Chan, MD, MPH